LARRY HICKS: Open Payments
NPI 1669004412 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 16 payments from 9 companies in 2025. Trend: 2023 $42 · 2024 $242 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Novus Surgical Consultants | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, FANAPT, RECORLEV, UBRELVY, LEQVIO, REXULTI.
Industry payments across ID — which companies pay providers there.
